ValVention Inc., an Irvine cardiovascular device company, received a $350,000 grant from the National Institutes of Health (NIH). The funding supports the study of ValVention’s FoldaValve, a transcatheter aortic valve replacement (TAVR) system, which can help restore blood flow to patients suffering from aortic valve stenosis – a disease in which the heart valve narrows and reduces blood flow to the body. … The device originated at California Institute of Technology and was developed at University of California, Irvine by Professor of [Biomedical] Engineering and Medicine Arash Kheradvar. [Subscription required, you can request an electronic copy of the article by sending an email to communications@uci.edu.] Read More